Clinical Trial Update: Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen [NA]

View source ↗

Summary

Completed clinical trial evaluating brain imaging changes after switching from efavirenz to a raltegravir-based regimen in people with HIV, focusing on HIV-asso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neurocognitive Disorder

Drugs mentioned

• Isentress (Raltegravir)
• Sustiva (efavirenz)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV, HIV-associated Neurocognitive Disorder | NA | Status: COMPLETED | Results posted: 2017-07-26